Startup India Government of India
Alencare Pharma Private Limited - pharma in Khalapur, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹13.73 Lakh
▼ 7% YoY
Net loss · FY 2025
₹5.77 Lakh
Net margin -42%
EBITDA · FY 2025
-₹5.77 Lakh
EBITDA margin -42%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹50,000
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Alencare Pharma Private Limited
Data last updated:
Alencare Pharma Private Limited is a private limited company based in Khalapur, Maharashtra, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 January 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2020PTC336782. Its GSTIN is 27AATCA2355A1ZT (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹50,000. It is led by directors Sanjay Kumar Verma and Priya Rani.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Office No 2 3 4 H No 03 Pendhar Section Tal Panvel District Raigad, Khalapur, Maharashtra, India – 410206.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.73 Lakh, a decline of 7% compared to the previous year. For the same year it recorded a net loss of ₹5.77 Lakh (net margin -42%) and EBITDA of -₹5.77 Lakh (EBITDA margin -42%). Revenue has declined at a compounded annual rate (CAGR) of 15% over three years.
The company is associated with 1 brand: Alencare Pharma. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
Alencare Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-27-0002335). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website alencarepharma.com.
Company details
CIN U51909MH2020PTC336782
Registration Number 336782
Incorporation Date 29 January 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-MH-27-0002335
Key People
Sanjay Kumar Verma Director Priya Rani Director Recognitions & Rankings of Alencare Pharma
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-27-0002335
Contact details
Alencare Pharma Private Limited's registered office is in Khalapur, Maharashtra. Its website is alencarepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressOffice No 2 3 4 H No 03 Pendhar Section Tal Panvel District Raigad, Khalapur, Maharashtra, India – 410206
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Alencare Pharma Private Limited, buy the company report.
Comprehensive company report
Alencare Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Alencare Pharma operates one associated brand: Alencare Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and supplies a range of diversified pharmaceutical drugs. | alencarepharma.com |
Business activity
The main business activity of Alencare Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Alencare Pharma Private Limited, buy the company report.
Financials of Alencare Pharma Private Limited
FY 2024 filings availableAlencare Pharma Private Limited reported revenue of ₹13.73 Lakh (down 7% YoY) for FY 2025.
Revenue · FY 2025
₹13.73 Lakh ▼ 7%
Net loss · FY 2025
₹5.77 Lakh margin -42%
EBITDA · FY 2025
-₹5.77 Lakh margin -42%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 7%
3 years · compounded
▼ 15%
EBITDA CAGR growth
1 year
▼ 242%
3 years · compounded
▼ 4%
Revenue has declined at a compounded annual rate (CAGR) of 15% over three years, including a 7% fall in the latest year. EBITDA fell 242% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹5.77 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹5.77 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -42% | ||||
| Net Profit Margin | -42% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Alencare Pharma Private Limited, buy the company report.
Board of directors of Alencare Pharma Private Limited
Alencare Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Kumar Verma Also directs: Susan Health Care Private Limited | Director | 10 Dec 2024 | 1 Years 10 Months | Current |
| Priya Rani Also directs: Susan Healthcare LLP | Director | 29 Jan 2020 | 6 Years 9 Months | Current |
Auditor
Alencare Pharma Private Limited is audited by A SAURABH & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A SAURABH & CO. | FY 2023 | 445413 |
Shareholding
The shareholding of Alencare Pharma Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Alencare Pharma Private Limited, buy the company report.
Legal cases
Alencare Pharma Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Total cases
1
Filed against the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Yamunanagar, Haryana | Cheque dishonour complaint | Filed against the company by Jaxrane Remidies Pvt. Ltd. | Pending |
To see the full case history of Alencare Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Alencare Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Alencare Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AATCA2355A1ZT | Maharashtra | Active | 15 Feb 2020 |
To see the full GST registrations and return filing status of Alencare Pharma Private Limited, buy the company report.
Recent activity
Alencare Pharma Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Anupam Rahul Singh ceased to be Director on 27 Dec 2024.
Ceased
Anupam Rahul Singh ceased to be Director.
Appointed
Sanjay Kumar Verma was appointed as Director.
AGM
Alencare Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Alencare Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Appointed
Priya Rani was appointed as Director.
Incorporation
29 Jan 2020
Alencare Pharma Private Limited was registered on 29 Jan 2020 with Roc Mumbai & aged 6 years 9 months as per MCA records.
Frequently asked questions
Alencare Pharma is an active private limited company based in Khalapur, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 January 2020 (6+ years old) and is registered under CIN U51909MH2020PTC336782.
Alencare Pharma has 2 current directors:
- Sanjay Kumar Verma - Director
- Priya Rani - Director
The latest financial statements of Alencare Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Alencare Pharma is 27AATCA2355A1ZT, registered in Maharashtra.
The CIN (Corporate Identification Number) of Alencare Pharma is U51909MH2020PTC336782. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alencare Pharma has 1 court case on record: 1 filed against it. 1 is pending.
Alencare Pharma was incorporated on 29 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
Anupam Rahul Singh ceased to be Director on 27 Dec 2024. Sanjay Kumar Verma was appointed as Director on 10 Dec 2024. Priya Rani was appointed as Director on 29 Jan 2020.
Yes, Alencare Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Alencare Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-27-0002335).